🇺🇸 FDA
Patent

US 6986891

Myeloma cell and ovarian cancer cell surface glycoproteins, antibodies thereto, and uses thereof

expired A61KA61K2039/505A61P

Quick answer

US patent 6986891 (Myeloma cell and ovarian cancer cell surface glycoproteins, antibodies thereto, and uses thereof) held by Molecular Discoveries, L.L.C. expires Mon Jan 12 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Molecular Discoveries, L.L.C.
Grant date
Tue Jan 17 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 12 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
25
CPC classes
A61K, A61K2039/505, A61P, A61P15/00, A61P19/00